Ranomend 500 ER Tablet
Marketer
Mendcure Life Sciences Pvt Ltd
Salt Composition
Ranolazine (500mg)
Overview Ranomend 500 ER Tablet
CardioMend 500 Extended Release tablets treat angina pectoris (chest pain stemming from heart issues). This medication helps prevent future angina episodes but won't halt an attack already in progress. It eases chest discomfort by improving cardiac function. Always take CardioMend 500 ER as prescribed by your physician, at the same time daily, with food to minimize stomach irritation. Dosage frequency is determined by your doctor and may adjust based on your response. Consistent use is crucial for optimal results, even during symptom-free periods, as it proactively reduces future risk. Discontinuing treatment may lead to a recurrence of chest pain. Supplementing medication with lifestyle improvements—such as smoking cessation, moderate alcohol consumption, a balanced diet, regular physical activity, and stress management—will further enhance heart health. Potential side effects include nausea, vomiting, headache, dizziness, constipation, and fatigue. Report any persistent or bothersome side effects to your physician. CardioMend 500 ER may not be appropriate for everyone. Inform your doctor about any liver or kidney conditions, and provide a complete list of all medications you're currently taking, as interactions may occur. Generally, this medication is not advised during pregnancy or breastfeeding.
Uses of Ranomend 500 ER Tablet
Managing chest pain associated with angina pectoris
Major Benefits of Ranomend 500 ER Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Ranomend 500 ER Tablet with a meal.
Common Side effects of Ranomend 500 ER Tablet:
- Nausea
- Vomiting
- Headache
- Dizziness
- Constipation
- Weakness
How to use Ranomend 500 ER Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ranomend 500 ER Tablets should be administered with a meal.
How Ranomend 500 ER Tablet works:
CardioMend 500 Extended-Release tablets offer angina relief. This effect is achieved through myocardial relaxation, thus reducing the heart's oxygen demand.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Ranomend 500 ER Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Extended-release Ranomend 500mg tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Ranomend 500mg tablets are likely not safe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
Driving ability may be unaffected by Ranomend 500 ER Tablet, however, refrain from operating a vehicle should concentration or reaction time be impaired.
KidneyCAUTION
Patients with kidney impairment should use Ranomend 500 ER Tablet cautiously, potentially requiring dosage modification. Medical advice is necessary. Ranomend 500 ER Tablet is contraindicated in individuals with severely compromised kidney function.
LiverCAUTION
Patients with liver impairment should use Ranomend 500 ER Tablet cautiously, potentially requiring dose modification. Consult a physician. Ranomend 500 ER Tablet is contraindicated in individuals with moderate to severe hepatic dysfunction.
What if you forget to take Ranomend 500 ER Tablet :
Should you forget to take a Ranomend 500 ER Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ranomend 500 ER Tablet
| Label | Value |
|---|---|
| Chemical Type | Piperazine-acetanilide hybrid |
| Developing Habits | No. |
| Treatment Category | Heart |
| Behavioral Class | Angina treated with late sodium channel blockers |


